ATYPICAL PNEUMONIAS: THE BASICS Nilesh Patel, DO October 8, 2008 St. Joseph’s Regional Medical Center.

Slides:



Advertisements
Similar presentations
Chest Infections Lawrence Pike.
Advertisements

Yong Lee ICU Registrar John Hunter Hospital
Bioterrorist Agents: Tularemia
PNEUMONIA Fadi J. Zaben RN MSN.
Pertussis. Highly contagious respiratory infection Classic pertussis, the whooping cough syndrome, usually is caused by B. Pertussis a gram-negative pleomorphic.
Pneumonia Ken Lyn-Kew, M.D..
Rachel S. Natividad, RN, MSN, NP N212 Medical Surgical Nursing 1 The Respiratory System.
Nikola Bla ž evi ć Mentor: A. Ž mega č Horvat. - inflammation of the lungs caused by infection - many different causes: bacteria, viruses, fungi, idiopathic.
Prof. Dr. Bilun Gemicioğlu
Pneumonia Why do we need to know about it? Long recognized as a major cause of death, Pneumonia has been studied intensively since late 1800s. Despite.
Pneumonia: nursing management Islamic University Nursing College.
Community-Acquired Pneumonia Nilesh Patel, D.O. October 8, 2008 St. Joseph’s Regional Medical Center Emergency Medicine Conference.
Chapter 22 Pulmonary Infections Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
28 June 2011 WHAT PATHOLOGY TESTS TO ORDER WHEN A PATIENT PRESENTS WITH ATYPICAL PNEUMONIA Stephen GRAVES Director Division of Microbiology.
CPC # 2 Infectious Disease October 7, 2008 Lisa L. Maragakis, MD MPH.
Streptococcus pneumoniae Chapter 23. Streptococcus pneumoniae S. pneumoniae was isolated independently by Pasteur and Steinberg more than 100 years ago.
COMMUNITY ACQUIRED PNEUMONIA…..AN OVERVIEW DR E. A. ODEGHE.
Lower Respiratory Tract Infection. Pneumonia Common with high morbidity and mortality rates. Acute respiratory infection with focal chest signs and radiographic.
Community acquired pneumonia A/Prof Peter Wark Department of Respiratory and Sleep Medicine John Hunter Hospital.
PATIENT TYPEETIOLOGY OutpatientStreptococcus pneumoniae Mycoplasma pneumoniae Haemophilus influenzae Chlamydophila pneumoniae Respiratory viruses* Non-ICU.
Bacterial Pneumonia Sung Chul Hwang, M.D. Dept. of Pulmonary and Critical Care Medicine Ajou University School of Medicine.
Copyright © 2004 Pearson Education, Inc., publishing as Benjamin Cummings PowerPoint ® Lecture Slide Presentation prepared by Christine L. Case Microbiology.
Welcome Submitted by:- Joshi Aditi Reg.No: Submitted to:- Dr. Anurag yadav.
Lower Respiratory Tract Infections in Children Abdelaziz Elamin Professor of Child Health University of Khartoum Sudan.
LOWER RESPIRATORY TRACT INFECTION Dr Ali Somily. Objectives  To know the epidemiology and main causes of lower respiratory tract infections  The understated.
Chapter 21 – Chlamydia, Mycoplasma, & Ureaplasma Species
Dr A.J.France © A.J.France Objectives  Define the range of conditions  Recognise the common clinical presentations  Understand the significance.
Bronchitis, Pneumonia, and Pleural Empyema
1 Respiratory Diseases in HIV-infected Patients HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Ali Somily MD.  Disease of alveoli and respiratory brochioles  Whole lobe, around brochi patchy (consuldation vs brocho-pneumonia) or interstial  Defined.
Batterjee Medical College. Dr. Manal El Said Chlamydiae Head of Medical Microbiology Department.
Plans for Diagnosis of Community Acquired Pneumonia.
HIV related Opportunistic Diseases HIV related Opportunistic Diseases M.MEIDANI,MPH.MD.
Chapter 22 Pulmonary Infections. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Objectives  State the incidence.
سورة البقرة ( ۳۲ ). Influenza is a serious respiratory illness which can be debilitating and causes complications that lead to hospitalization and.
 Bacteria  Viruses  Fungi  Parasites  Idiopathic.
Infectious Respiratory Diseases
LegionellaceaeLegionellaceae Fastidious Gram-Negative Bacilli.
Serum procalcitonin and C-reactive protein in children with community- acquired pneumonia K.Gogvadze, I.Guramishvili, I.Chkhaidze, K.Nemsadze, T.Maglakelidze.
Mycoplasmal pneumonia Pneumonia caused by Mycoplasma pneumoniae, often accompanied by pharyngitis and bronchitis.
Clinical Aspects of Severe Acute Respiratory Syndrome (SARS), 2003 John A. Jernigan, MD, MS For the SARS Clinical/Infection Control Investigative Team.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Chapter 26 Infectious Diseases.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student under Nephrology Division under the supervision and administration.
Influenza Causative Agent Orthomyxovirus Influenza A virus
Chronic Bronchitis Breathlessness, and Productive purulent cough, and Fever Chest X-ray for to exclude lung neoplasm,
Atypical Bacterial Pneumonia
بسم الله الرحمن الرحيم GENUS: LEGIONELLA Prof. Khalifa Sifaw Ghenghesh.
Pneumonia Egan’s Chapter 22. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Introduction Infection involving the.
Severe acute respiratory syndrome. SARS. SARS is a communicable viral disease caused by a new strain of coronavirus. The most common symptoms in patient.
NYU Medical Grand Rounds Clinical Vignette Benjamin Eckhardt, MD PGY-3 October 6, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
1 Pneumonia. 2 Pneumonia  Mild case--walking pneumonia  Entire lobe--lobar pneumonia  Segment of a lobe--segmental or lobular pneumonia  Alveoli close.
Bordatella Pertussis Adaobi Okobi, M.D..
Brucella. Brucellosis (undulant fever) is a zoonosis Members of the genus Brucella are primarily pathogens of animals Different species of Brucella are.
Classic Presentation of Inhalational Anthrax Initial phase -Malaise, fatigue, fever, myalgias, non-productive cough -1-4 days Fulminant phase -Respiratory.
Community Acquired Pneumonia Peter Valenzuela, MD, MBA, FAAFP Assistant Dean for Clinical Affairs Assistant Professor/Dept. of Family Medicine.
Community-Acquired Pneumonia Richard G. Wunderink, M.D., and Grant W. Waterer, M.B., B.S., Ph.D. N Engl J Med 2014;370: R3 김선혜 /Prof. 박명재 1.
Pneumonia in infancy and childhood
Comparison between pathogen directed antibiotic treatment and empiri cal broad spectrum antibiotic treatment in patients with community acquired pneumonia.
ABDULLAH M. AL-OLAYAN MBBS, SBP, ABP. ASSISTANT PROFESSOR OF PEDIATRICS. PEDIATRIC PULMONOLOGIST. PNEUMONIA.
PNEUMONIA BY: NICOLE STEVENS.
PNEUMONIA DR. FAWAD AHMAD RANDHAWA M.B.B.S. ( KING EDWARD MEDICAL COLLEGE) M.C.P.S; F.C.P.S. ( MEDICINE) F.C.P.S. ( ENDOCRINOLOGY) ASSISTANT PROFESSOR.
APIC Chapter 13 Journal Club March 16, 2015 Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults NEJM – July 30, :5 Presented.
Infective endocarditis
Pneumonia Salutations:
Pneumonia in Children. What is pneumonia? Pneumonia is an inflammation of the lungs caused by bacteria, viruses, or chemical irritants. It is a serious.
PHARMACOTHERAPY III PHCY 510
Pneumocystis carinii Pneumonia
Community acquired pneumonia (CAP)
Community acquired pneumonia (CAP)
Presentation transcript:

ATYPICAL PNEUMONIAS: THE BASICS Nilesh Patel, DO October 8, 2008 St. Joseph’s Regional Medical Center

QUESTIONS WE WILL ANSWER???  What is an atypical pneumonia?  What are the organisms that compromise atypical pneumonias?  How do we test for atypical pneumonias; does it matter?  What are the antibiotic choices?  What should we think about when HIV patients present with pneumonia?

OBJECTIVES  We will discuss….  Mycoplasma pneumoniae  Legionella sp.  Chlamydia pneumoniae  Chlamydia psittaci  Viral pneumonias  Pneumonia in the setting of HIV/AIDS--PCP

ATYPICAL PNEUMONIA: WHAT IS IT???  Infection of pulmonary parenchyma  Community-acquired  Classically—do not show up on Gram stain  Characteristics  “Atypical” presentation/symptoms/diagnostics  Insidious onset  Nonproductive cough  Constitutional symptoms  Interstitial pattern on CXR  Smoldering course  The lines are “blurred”  Similar to typical organisms clinically and radiographically

ORGANISMS  Mycoplasma pneumonia  Viral pneumonias  RSV  Parainfluenza  Adenovirus  Influenza  Other  Chlamydia pneumonia  Chlamydia psittaci  Legionella pneumophila  Coxiella burnetti (Q fever pneumonia)  Francisella tularensis (Tularemia)

EPIDEMIOLOGY  4 million cases CAP/year  20-60% typical organisms  10-40% atypical organisms  Hard to quantify these organisms

PATHOPHYSIOLOGY

MYCOPLASMA PNEUMONIA  Smallest free living organisms  Prokaryotes  No cell wall  Most common cause of atypical pneumonia  “Walking” pneumonia  Community acquired  Usually occur in young to middle aged patient  Clinical symptoms  Insidious onset, protracted course  Constitutional symptoms (fevers, chills, myalgias, body aches)  Sore throat, HA  Dry cough  Chest pain/SOB

MYCOPLASMA: DIAGNOSTICS  CXR  Consolidation  Patchy infiltrates  Interstitial pattern  Pleural effusion  Labs  WBC  Cold agglutinin assays  Other serum assays  Cultures  Blood  Sputum

MYCOPLASMA: TMT  Macrolides  Azithromycin  Erythromycin  Clarithromycin  Doxycycline

LEGIONELLA  Gram negative intracellular rods  Fastidious  Multiple serotypes  Legionella pneumophila  Community acquired  Legionnaire’s disease  Transmission from contaminated water sources  Warm water environments  No person to person transmission  Outbreaks….Sporadic cases  High mortality if not treated

LEGIONELLA  Natural water habitats  Water distribution systems  Cooling towers  Hot tubs/Spas  Respiratory equipment  Humidifiers  Etc……  Travel  Hotels  Large Events  Floods/Natural Disasters

LEGIONELLA: SYMPTOMS  Incubation period: 2-10 days  Clinical symptoms  Pulmonary  Cough  Chest pain  Dyspnea  Extrap-pulmonary  Constitutional symptoms  GI symptoms—diarrhea, abd pain, n/v  Neuro symptoms—HA, change in mental status

LEGIONELLA: DIAGNOSTICS  CXR—variable  Consolidation  Patchy infiltrates/Interstitial infiltrates  Pleural effusions  Multi-lobar  Labs  CBC, SMA-7 (Hyponatremia, Elevated LFTs, ARF)  CPK  Urine antigen tests  Serum legionella antibodies  PCR  Cultures  Sputum gram stain/culture; DFA sputum  Blood cultures

LEGIONELLA: TMTS  Fluoroquinolones  Levaquin  Avelox  Macrolides  Zithromax  Doxycycline  Bactrim  Rifampin  Extended course  Initial IV therapy

CHLAMYDIA  Chlamydia 3 sp (pneumoniae, psittaci, trachomatis)  Gram negative obligate intracellular organisms (parasites)  Unique organisms  Community acquired  Chlaymydia pneumoniae  Common  Respiratory transmission (person to person)  Pneumonia  Chlaymdia psittaci  Rare  Ornithosis  Respiratory transmission (infected birds to humans)  Pneumonia/Viral illness

CHLAMYDIA PNEUMONIA  Clinical symptoms  Incubation period: 1-4 weeks  Acute/subacute illness  Self limited URI/bronchitis  Fever  Constitutional symptoms  Cough  Chest pain/sob  Pharyngitis  Sinusitis  Rales/Rhonchi/Wheezing

CHLAYMDIA PSITACCI  Risk Factors—Contact with birds  Clinical symptoms (incubation 5-30 days)  Acute viral illness/flu like symptoms  Fever  Relative bradycardia  Constitutional symptoms  Chest pain/sob  Multi-system  Neuro symptoms—HA, altered mental status  HSM (elevated LFTs)  Rash—Horder spots, EM, EN  Rales/Rhonchi/Wheezing/Clear lungs

CHLAMYDIA: DIAGNOSTICS  Chlamydia pneumonia  CXR  Cultures  Serologic tests  Chlamydia psitacci  CXR  Cultures  Serologic tests

CHLAMYDIA: TMTS  Chlamydia pneumoniae  Doxycycline/Tetracycline  Macrolides (Zithromax, Clarithromycin, E-mycin)  Quinolones (Avelox, Levaquin)  Chlamydia psitacci  Doxycycline/Tetracycline  Macrolides (Zithromax, E-mycin)

VIRAL PNEUMONIAS  More common in pediatric population and elderly  Up to 15% of all CAP cases  Mild>>>>Severe  Influenza A & B  RSV  Adenoviruses  Parainfluenza  SARS  Avian flu  Varicella  CMV  Herpes virus  Hanta virus

ANTIBIOTICS  Outpatient/Inpatient/ICU  Remember coverage for CAP  Mycoplasma—Macrolide, Doxy  Legionella—Quinolone, Macrolide  Chlaymydia pneumonia—Doxy, Macrolide  Chlaymida psitacci—Doxy, Macrolide  Viral pneumonias  Supportive care  Influenza—Tamiflu, think Staph coverage

HIV & PNEUMONIA  Most common infectious process in HIV + patients  Broaden differential diagnosis  CD4 count & viral load important for specific organisms and prognosis  CAP most common  Other  PCP  TB  MAC  Histoplasmosis/Coccidiomycosis  Viral pneumonias

PCP  Pneumocystis carinii >> Pneumocystis jiroveci  Unicellular fungus  Various morphology--cysts  Pre-HIV—few cases  Most common opportunistic infection in HIV patients  Common cause of death in HIV patients; mortality ~ 15%  Decreased incidence with prophylaxis and antiretroviral treatment  Transmission—human to human; airborne  Pneumocystis is widespread  Symptomatic disease occurs in immunosuppressed populations

PCP: CLINICAL SYMPTOMS  Symptoms  SOB (exertional)  Cough  Fevers  Constitutional symptoms  Chest pain  Signs  Tachypnea/Fever/Tachycardia  Rales/RhonchiWheezing  Cachexia  Lymphadenopathy  Cyanosis

PCP: DIAGNOSTICS  Labs  CBC, SMA-7  LDH  ABG  Imaging  CXR—variable  Normal>>Diffuse b/l infiltrates>>Perihilar infiltrates>>PTX  CT scan  Diffuse b/l infiltrates>>Ground glass appearance>>Cysts  Sputum culture  BAL  Complication—PTX!

PCP: TMT  Supportive treatments  Oxygen  Noninvasive/Invasive ventilation  Antibiotics (14-21 days or until clinical response achieved)  Bactrim IV  Pentamadine IV or aerosolized  Atovaquone po  Other therapies  Steroids—Hypoxemia, PaO2 < 70, Severe disease  Prophylaxis

PCP: COMPLICATIONS  Hypoxemic respiratory failure  ARDS  PTX  Risk for other opportunistic infections

SUMMARY  Atypical pneumonias  Mycoplasma  Legionella  Chlamydia  Viral pneumonias  HIV & pneumonia  PCP